vs
Side-by-side financial comparison of Black Stone Minerals, L.P. (BSM) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Black Stone Minerals, L.P. is the larger business by last-quarter revenue ($95.2M vs $57.3M, roughly 1.7× RHYTHM PHARMACEUTICALS, INC.). Black Stone Minerals, L.P. runs the higher net margin — 75.9% vs -83.0%, a 158.9% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -8.7%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -9.7%).
Black Stone Minerals, L.P., or Black Stone Minerals, is a Houston, Texas-based oil and natural gas corporation.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
BSM vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $95.2M | $57.3M |
| Net Profit | $72.2M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 78.6% | -82.2% |
| Net Margin | 75.9% | -83.0% |
| Revenue YoY | -8.7% | 36.9% |
| Net Profit YoY | 55.8% | -9.6% |
| EPS (diluted) | — | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $95.2M | $57.3M | ||
| Q3 25 | $105.2M | $51.3M | ||
| Q2 25 | $106.7M | $48.5M | ||
| Q1 25 | $115.3M | $32.7M | ||
| Q4 24 | $104.3M | $41.8M | ||
| Q3 24 | $103.2M | $33.3M | ||
| Q2 24 | $115.2M | $29.1M | ||
| Q1 24 | $116.8M | $26.0M |
| Q4 25 | $72.2M | $-47.5M | ||
| Q3 25 | $91.7M | $-52.9M | ||
| Q2 25 | $120.0M | $-46.6M | ||
| Q1 25 | $15.9M | $-49.5M | ||
| Q4 24 | $46.3M | $-43.3M | ||
| Q3 24 | $92.7M | $-43.6M | ||
| Q2 24 | $68.3M | $-32.3M | ||
| Q1 24 | $63.9M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | 78.6% | -82.2% | ||
| Q3 25 | 89.5% | -102.6% | ||
| Q2 25 | — | -93.4% | ||
| Q1 25 | 14.9% | -143.7% | ||
| Q4 24 | 45.6% | -98.6% | ||
| Q3 24 | 90.2% | -132.0% | ||
| Q2 24 | 59.5% | -139.2% | ||
| Q1 24 | 54.8% | -538.7% |
| Q4 25 | 75.9% | -83.0% | ||
| Q3 25 | 87.2% | -103.1% | ||
| Q2 25 | 112.5% | -96.1% | ||
| Q1 25 | 13.8% | -151.4% | ||
| Q4 24 | 44.4% | -103.6% | ||
| Q3 24 | 89.9% | -131.2% | ||
| Q2 24 | 59.3% | -110.9% | ||
| Q1 24 | 54.7% | -544.4% |
| Q4 25 | — | $-0.73 | ||
| Q3 25 | — | $-0.82 | ||
| Q2 25 | — | $-0.75 | ||
| Q1 25 | — | $-0.81 | ||
| Q4 24 | — | $-0.71 | ||
| Q3 24 | — | $-0.73 | ||
| Q2 24 | — | $-0.55 | ||
| Q1 24 | — | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $139.1M |
| Total Assets | $1.3B | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $388.9M | ||
| Q3 25 | $2.9M | $416.1M | ||
| Q2 25 | $2.5M | $291.0M | ||
| Q1 25 | $2.4M | $314.5M | ||
| Q4 24 | $2.5M | $320.6M | ||
| Q3 24 | $21.0M | $298.4M | ||
| Q2 24 | $26.7M | $319.1M | ||
| Q1 24 | $40.5M | $201.2M |
| Q4 25 | — | $139.1M | ||
| Q3 25 | — | $148.8M | ||
| Q2 25 | — | $-11.9M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | — | $11.2M | ||
| Q2 24 | — | $39.3M | ||
| Q1 24 | — | $61.6M |
| Q4 25 | $1.3B | $480.2M | ||
| Q3 25 | $1.3B | $506.9M | ||
| Q2 25 | $1.3B | $372.7M | ||
| Q1 25 | $1.2B | $386.7M | ||
| Q4 24 | $1.2B | $392.3M | ||
| Q3 24 | $1.2B | $363.6M | ||
| Q2 24 | $1.2B | $381.8M | ||
| Q1 24 | $1.2B | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $65.1M | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.1M | $-25.4M | ||
| Q3 25 | $99.8M | $-26.6M | ||
| Q2 25 | $80.5M | $-23.3M | ||
| Q1 25 | $64.8M | $-40.4M | ||
| Q4 24 | $91.0M | $-18.8M | ||
| Q3 24 | $93.2M | $-25.2M | ||
| Q2 24 | $100.4M | $-29.1M | ||
| Q1 24 | $104.5M | $-40.7M |
| Q4 25 | 0.90× | — | ||
| Q3 25 | 1.09× | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 4.07× | — | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.47× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BSM
| Oil Reserves | $46.4M | 49% |
| Natural Gas Reserves | $44.1M | 46% |
| Real Estate | $4.7M | 5% |
RYTM
Segment breakdown not available.
